A Refined Study of FCRL Genes from a Genome-Wide Association Study for Graves' Disease

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Zhao, Shuang Xia ^a   Liu, Wei ^a   Zhan, Ming ^a   Song, Zhi Yi ^a   Yang, Shao Ying ^a   Xue, Li Qiong ^a   Pan, Chun Ming ^a   Gu, Zhao Hui ^a,b   Liu, Bing Li ^a   Wang, Hai Ning ^a   Liang, Liming ^c   Liang, Jun ^d   Zhang, Xiao Mei ^e   Yuan, Guo Yue ^f   Li, Chang Gui ^g   Chen, Ming Dao ^a   Chen, Jia Lun ^a   Gao, Guan Qi ^h   Song, Huai Dong ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b Shanghai Jiao Tong University   (China)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d XUZHOU MEDICAL UNIVERSITY   (China)

^e BENGBU MEDICAL COLLEGE   (China)

^f AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^g QINGDAO UNIVERSITY   (China)

^h LINYI PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD16 ANTIGEN; CD19 ANTIGEN; FC RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EPIGENETICS; FC RECEPTOR LIKE 3 GENE; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GRAVES DISEASE; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BINDING; QUANTITATIVE TRAIT LOCUS; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE SUBPOPULATION; UPREGULATION;

CHROMOSOMES, HUMAN, PAIR 1; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; GRAVES DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; RECEPTORS, FC;

EID: 84874722538     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057758     Document Type: Article

References (39)

1. Simmonds MJ, Howson JM, Heward JM, Cordell HJ, Foxall H, et al. (2005) Regression mapping of association between the human leukocyte antigen region and Graves' disease. Am J Hum Genet 76: 157-163.
2. Simmonds MJ, Howson JM, Heward JM, Carr-Smith J, Franklyn JA, et al. (2007) A novel and major association of HLA-C in Graves' disease that eclipses the classical HLA-DRB1 effect. Hum Mol Genet 16: 2149-2153.
3. Ueda H, Howson JM, Esposito L, Heward J, Snook H, et al. (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423: 506-511.
4. Zhao SX, Pan CM, Cao HM, Han B, Shi JY, et al. (2010) Association of the CTLA4 gene with Graves' disease in the Chinese Han population. PloS one 5: e9821.
5. Ban Y, Tozaki T, Tobe T, Jacobson EM, Concepcion ES, et al. (2007) The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J Autoimmun 28: 201-207.
6. Jacobson EM, Concepcion E, Oashi T, Tomer Y, (2005) A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology 146: 2684-2691.
7. McGonagle D, McDermott MF, (2006) A proposed classification of the immunological diseases. PLoS Med 3: e297.
8. Barbesino G, Tomer Y, Concepcion ES, Davies TF, Greenberg DA, (1998) Linkage analysis of candidate genes in autoimmune thyroid disease. II. Selected gender-related genes and the X-chromosome. J Clin Endocrinol Metab 83: 3290-3295.
9. Imrie H, Vaidya B, Perros P, Kelly WF, Toft AD, et al. (2001) Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population. J Clin Endocrinol Metab 86: 626-630.
10. Song HD, Liang J, Shi JY, Zhao SX, Liu Z, et al. (2009) Functional SNPs in the SCGB3A2 promoter are associated with susceptibility to Graves' disease. Human Molecular Genetics 18: 1156-1170.
11. Chistiakov DA, Voronova NV, Turakulov RI, Savost'anov KV (2010) The- 112G> A polymorphism of the secretoglobin 3A2 (SCGB3A2) gene encoding uteroglobin-related protein 1 (UGRP1) increases risk for the development of Graves' disease in subsets of patients with elevated levels of immunoglobulin E. Journal of Applied Genetics: 1-7.
12. Simmonds MJ, Yesmin K, Newby PR, Brand OJ, Franklyn JA, et al. (2010) Confirmation of Association of Chromosome 5q31-33 with United Kingdom Caucasian Graves' Disease. Thyroid 20: 413-417.
13. Hiratani H, Bowden DW, Ikegami S, Shirasawa S, Shimizu A, et al. (2005) Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease. J Clin Endocrinol Metab 90: 2898-2903.
14. Brand OJ, Barrett JC, Simmonds MJ, Newby PR, McCabe CJ, et al. (2009) Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease. Hum Mol Genet 18: 1704-1713.
15. Eisenbarth GS, Moriyama H, Robles DT, Liu E, Yu L, et al. (2002) Insulin autoimmunity: prediction/precipitation/prevention type 1A diabetes. Autoimmun Rev 1: 139-145.
16. Kochi Y, Yamada R, Suzuki A, Harley JB, Shirasawa S, et al. (2005) A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 37: 478-485.
17. Chistiakov DA, Chistiakov AP, (2007) Is FCRL3 a new general autoimmunity gene? Hum Immunol 68: 375-383.
18. Mao C, Pan H, Chen Q, Wang X, Ye D, et al. (2010) Association between Fc receptor-like 3 C169T polymorphism and risk of systemic lupus erythematosus: a meta-analysis. Molecular biology reports 37: 191-196.
19. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, et al. (2007) Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 39: 1329-1337.
20. Van De Velde V, Courtens W, Bernard A, (2010) Development of a new sensitive ELISA for the determination of uteroglobin-related protein 1, a new potential biomarker. Biomarkers 15: 619-624.
21. Kocjan T, Wraber B, Repnik U, Hojker S, (2000) Changes in Th1/Th2 cytokine balance in Graves' desease. Pflugers Arch 440: 94-95.
22. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
23. Howie BN, Donnelly P, Marchini J, (2009) A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 5: e1000529.
24. Marchini J, Howie B, Myers S, McVean G, Donnelly P, (2007) A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39: 906-913.
25. Dixon AL, Liang L, Moffatt MF, Chen W, Heath S, et al. (2007) A genome-wide association study of global gene expression. Nat Genet 39: 1202-1207.
26. Zeller T, Wild P, Szymczak S, Rotival M, Schillert A, et al. (2010) Genetics and beyond-the transcriptome of human monocytes and disease susceptibility. PloS one 5: e10693.
27. Fairfax BP, Makino S, Radhakrishnan J, Plant K, Leslie S, et al. (2012) Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles. Nature genetics 44: 502-510.
28. Breslow NE, Day NE (1980) Statistical methods in cancer research. Volume I- The analysis of case-control studies. IARC Sci Publ: 5-338.
29. Cooper JD, Simmonds MJ, Walker NM, Burren O, Brand OJ, et al. (2012) Seven newly identified loci for autoimmune thyroid disease. Hum Mol Genet 21: 5202-5208.
30. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, et al. (1998) Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 26: 362-367.
31. Cappelli C, Gandossi E, Castellano M, Pizzocaro C, Agosti B, et al. (2007) Prognostic value of thyrotropin receptor antibodies (TRAb) in Graves' disease: a 120 months prospective study. Endocr J 54: 713-720.
32. Sgarbi JA, Kasamatsu TS, Matsumura LK, Maciel RMB, (2010) Parity Is not related to autoimmune thyroid disease in a population-based study of Japanese-Brazilians. Thyroid 20: 1151-1156.
33. Owen CJ, Kelly H, Eden JA, Merriman ME, Pearce SH, et al. (2007) Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J Clin Endocrinol Metab 92: 1106-1111.
34. Maller JB, McVean G, Byrnes J, Vukcevic D, Palin K, et al. (2012) Bayesian refinement of association signals for 14 loci in 3 common diseases. Nat Genet 44: 1294-1301.
35. Miller I, Hatzivassiliou G, Cattoretti G, Mendelsohn C, Dalla-Favera R, (2002) IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells. Blood 99: 2662-2669.
36. Davis RS, (2007) Fc receptor-like molecules. Annual Review of Immunology 25: 525-560.
37. Matesanz-Isabel J, Sintes J, Llinàs L, de Salort J, Lázaro A, et al. (2011) New B-cell CD molecules. Immunology letters 134: 104-112.
38. Kochi Y, Myouzen K, Yamada R, Suzuki A, Kurosaki T, et al. (2009) FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling. The Journal of Immunology 183: 5502-5510.
39. Swainson LA, Mold JE, Bajpai UD, McCune JM, (2010) Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1. J Immunol 184: 3639-3647.